Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000912057-00-052220
Filing Date
2000-12-05
Accepted
2000-12-05 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 a2032359zs-3.txt S-3 60053
2 EX-5.1 a2032359zex-5_1.txt EX-5.1 2477
3 EX-23.1 a2032359zex-23_1.txt EX-23.1 256
4 EX-23.2 a2032359zex-23_2.txt EX-23.2 717
  Complete submission text file 0000912057-00-052220.txt   65301
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-51250 | Film No.: 783422
SIC: 2836 Biological Products, (No Diagnostic Substances)